| Authors: |
Singh K; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Hotchkiss KM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Parney IF; Mayo Clinic, Rochester, MN, USA., De Groot J; Division of Neuro-Oncology, Department of Neurological Surgery, University of California San Francisco (UCSF), San Francisco, CA, USA., Sahebjam S; National Institute of Health, Bethesda, MD, USA., Sanai N; Ivy Brain Tumor Center, The Barrow Neurological Institute, Phoenix, AZ, USA., Platten M; Medical Faculty Mannheim, Heidelberg University, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Galanis E; Mayo Clinic, Rochester, MN, USA., Lim M; Department of Neurosurgery, Stanford University, School of Medicine, Stanford, CA, USA., Wen PY; Center for Neuro-Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy., Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Cloughesy TF; Neuro-Oncology Program, University of California Los Angeles (UCLA), Los Angeles, CA, USA., Mehta MP; Miami Cancer Institute, Miami, FL, USA., Geurts M; Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA, USA., Desjardins A; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Tanner K; National Brain Tumor Society (NBTS), Newton, MA, USA., Short S; School of Medicine, University of Leeds, Leeds, UK., Arons D; National Brain Tumor Society (NBTS), Newton, MA, USA., Duke E; US Food and Drug Administration, Silver Spring, MD, USA., Wick W; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurooncology, Heidelberg University, Heidelberg, Germany., Bagley SJ; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ashley DM; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Kumthekar P; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Verhaak R; School of Medicine, Yale University, New Haven, CT, USA., Chalmers AJ; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Patel AP; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA., Watts C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK., Fecci PE; Surgical Neuro-Oncology, Department of Neurology, Duke University Medical Center, Durham, NC, USA., Batchelor TT; Brigham and Women's Hospital, Boston, MA, US., Weller M; Department of Neurology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Vogelbaum MA; Department of NeuroOncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, USA., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Berger MS; Department of Neurological Surgery, UCSF Brain Tumor Center, San Francisco, CA, USA., Khasraw M; The Preston Robert Tisch Brain Tumor Center at Duke, Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. mustafa.khasraw@duke.edu. |
